Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Pseudomonas fragi
Quality-of-life improvement and cost-effectiveness of interventional pulmonary procedures.
Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Use of multisystemic therapy to improve antiretroviral adherence and health outcomes in HIV-infected pediatric patients: evaluation of a pilot program.
Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next?
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next?
Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next? Curr Psychiatry Rep. 2006 Dec; 8(6):445-51.
View in:
PubMed
subject areas
Bipolar Disorder
Chronic Disease
Clinical Trials as Topic
Depressive Disorder, Major
Drug Resistance
Electric Stimulation Therapy
Humans
Recurrence
Vagus Nerve
authors with profiles
Mark S George